Monoclonal Antibody Prevents Malaria in Small NIH Trial
August 13, 2021
August 13, 2021
WASHINGTON, Aug. 13 (TNSJou) -- The U.S. Department of Health and Human Services' National Institutes of Health issued the following news release on Aug. 11, 2021:
One dose of a new monoclonal antibody discovered and developed at the National Institutes of Health safely prevented malaria for up to nine months in people who were exposed to the malaria parasite. The small, carefully monitored clinical trial is the first to demonstrate that a monoclonal antibody can prevent malari . . .
One dose of a new monoclonal antibody discovered and developed at the National Institutes of Health safely prevented malaria for up to nine months in people who were exposed to the malaria parasite. The small, carefully monitored clinical trial is the first to demonstrate that a monoclonal antibody can prevent malari . . .